GABRIEL LOPEZ to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications GABRIEL LOPEZ has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.208
-
Inhibition of Grb2 and Crkl proteins results in growth inhibition of Philadelphia chromosome positive leukemic cells. Biochem Biophys Res Commun. 1997 Jun 18; 235(2):383-8.
Score: 0.063
-
Liposomal delivery of methylphosphonate antisense oligodeoxynucleotides in chronic myelogenous leukemia. Blood. 1994 Jul 15; 84(2):601-7.
Score: 0.052
-
Interferon affects nuclear proteins in cells of clinically sensitive chronic myelogenous leukemia patients. Blood. 1990 Sep 15; 76(6):1117-30.
Score: 0.040
-
Specificity of BCR-ABL antisense oligonucleotides. Blood. 1995 Jan 15; 85(2):597-8.
Score: 0.027
-
Liposomal delivery of oligodeoxynucleotides. Leuk Lymphoma. 1996 Mar; 21(1-2):93-7.
Score: 0.014
-
Regulation of gene expression by tumor necrosis factor-alpha and interferon-gamma in chronic myelogenous leukemia. Trans Assoc Am Physicians. 1990; 103:236-41.
Score: 0.009
-
Activation of class I HLA expression by TNF-alpha and gamma-interferon is mediated through protein kinase C-dependent pathway in CML cell lines. Br J Haematol. 1991 Jul; 78(3):359-67.
Score: 0.003